Inhibrx (NASDAQ:INBX) & Halozyme Therapeutics (NASDAQ:HALO) Head-To-Head Review
Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) and Inhibrx (NASDAQ:INBX – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership. Profitability This table compares Halozyme Therapeutics and Inhibrx’s net […]
More Stories
Pebblebrook Hotel Trust (NYSE:PEB) CEO Jon E. Bortz Purchases 13,000 Shares
Pebblebrook Hotel Trust (NYSE:PEB – Get Free Report) CEO Jon E. Bortz purchased 13,000 shares of the company’s stock in...
Altria Group, Inc. (NYSE:MO) Stock Holdings Lowered by Pitcairn Co.
Pitcairn Co. lowered its position in shares of Altria Group, Inc. (NYSE:MO – Free Report) by 12.8% in the 3rd...
Agrify Announces Completion of $25.9 Million Non-Brokered Private Placement
Agrify Corporation (NASDAQ: AGFY) recently finalized Securities Purchase Agreements with institutional and accredited investors for a non-brokered private placement transaction....
Addentax Group (NASDAQ: ATXG) Signs MOU with Yingbin Brand for Strategic Collaboration
Addentax Group Corp. announced on November 21, 2024, the signing of a memorandum of understanding (MOU) with Shenzhen Yingbin Brand...
TScan Therapeutics (NASDAQ:TCRX) Receives Notice for Conversion of $15 Million Loan into Common Stock
TScan Therapeutics, Inc. recently disclosed in an 8-K filing to the Securities and Exchange Commission that the company has received...
TKO Group Holdings, Inc. Refinances Existing Credit Agreement
TKO Group Holdings, Inc. (NYSE: TKO) announced on November 21, 2024, that its subsidiary, UFC Holdings, LLC, entered into the...